Researchers found that when given to infant rats, the drugs caused behavioral abnormalities later in life. What’s more, the abnormalities were not limited to the drugs known to cause neuronal cell death. “That is of particular concern because some of the drugs may predispose to psychiatric disorders later in life,” says lead author Patrick Forcelli.
“Pfizer targeted pediatrics and adolescents to expand off-label use and maintained on its payroll an army of more than 250 child psychiatrists nationwide. Pfizer regularly paid generous speaking fees to these child psychiatrists to give what were basically promotional lectures about the benefits of Geodon to their peers, who were naturally also child psychiatrists, despite the fact the drug is not FDA-approved or medically indicated to treat children at all.” According to (filing attorney), “the purpose and intent of paying so many child psychiatrists is clear — to gain a foothold within the fastest growing market for antipsychotics — children.”
Created to treat schizophrenia, Zyprexa wound up being used on misbehaving kids.